Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 29, 2018 23:46 ET | Source: Lexington Biosciences, Inc.

Lexington Announces Q3 2018 Financial Results and Non-Brokered Private Placement

VANCOUVER, British Columbia, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announces the release of the Company’s Condensed...
August 27, 2018 09:00 ET | Source: Lexington Biosciences, Inc.

Lexington Announces Non-Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, Aug. 27,...
August 21, 2018 09:00 ET | Source: Lexington Biosciences, Inc.

Lexington Announces First Multicenter Clinical Study Site

VANCOUVER, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
July 02, 2018 19:32 ET | Source: Lexington Biosciences, Inc.

Lexington Biosciences Announces Results of Annual General Meeting

VANCOUVER, British Columbia, July 02, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, wishes...
June 11, 2018 07:45 ET | Source: Lexington Biosciences, Inc.

Lexington Biosciences Announces Amended Terms to Previously Announced Brokered Financing

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, June 11,...
May 04, 2018 07:00 ET | Source: Lexington Biosciences, Inc.

Lexington Announces Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, B.C., May 04, 2018 (GLOBE...
January 24, 2018 09:00 ET | Source: Lexington Biosciences, Inc.

Lexington Receives Approval to Commence Clinical Study

VANCOUVER, British Columbia, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
January 18, 2018 09:00 ET | Source: Lexington Biosciences, Inc.

Lexington Completes IRB Submission in Preparation for Clinical Study

VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device...
January 11, 2018 09:00 ET | Source: Lexington Biosciences, Inc.

Lexington Biosciences Announces Exercise of Warrants

VANCOUVER, British Columbia, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...